These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1624677)

  • 21. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.
    Wehrenberg WB; Baird A; Ying SY; Rivier C; Ling N; Guillemin R
    Endocrinology; 1984 Jun; 114(6):1995-2001. PubMed ID: 6327231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins in hypothalamo-pituitary and ovarian function.
    Behrman HR
    Annu Rev Physiol; 1979; 41():685-700. PubMed ID: 373605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic-pituitary function in patients with craniopharyngiomas.
    Jenkins JS; Gilbert CJ; Ang V
    J Clin Endocrinol Metab; 1976 Aug; 43(2):394-9. PubMed ID: 820710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities.
    Maghnie M; Triulzi F; Larizza D; Preti P; Priora C; Scotti G; Severi F
    J Clin Endocrinol Metab; 1991 Jul; 73(1):79-83. PubMed ID: 1904454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat.
    Lumpkin MD; Samson WK; McCann SM
    Endocrinology; 1983 May; 112(5):1711-7. PubMed ID: 6403333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and growth in a woman with untreated hypothalamic panhypopituitarism of 21 years' duration.
    Tolis G; Cruess S; Goldstein M; Friesen HG; Rochefort JG
    Can Med Assoc J; 1974 Sep; 111(6):553-6. PubMed ID: 4370418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis.
    Johnson EO; Kamilaris TC; Calogero AE; Gold PW; Chrousos GP
    Eur J Endocrinol; 2005 Jul; 153(1):177-85. PubMed ID: 15994759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pyridoxine on pituitary release of growth hormone and prolactin in childhood and adolescence.
    Reiter EO; Root AW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):689-90. PubMed ID: 263321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
    Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Growth and some endocrinological parameters in thalassemia major, with special reference to growth hormone].
    Colombo A; Larizza D; Garibaldi E; Bozzola M; Gasparoni MC; Peretti L
    Minerva Pediatr; 1977 May; 29(19):1225-39. PubMed ID: 882068
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypothalamic factors differentially affect the proportions of cells that secrete growth hormone or prolactin.
    Hoeffler JP; Frawley LS
    Endocrinology; 1987 Feb; 120(2):791-5. PubMed ID: 3100281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone response to thyrotropin-releasing hormone in liver cirrhosis: unique alteration in anterior pituitary responsiveness to hypothalamic hormones.
    Salerno F; Cocchi D; Lampertico M; Manneschi M; Monza G; Müller EE
    Horm Metab Res; 1982 Sep; 14(9):482-6. PubMed ID: 6128295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of endogenous opiates on anterior pituitary function.
    Van Vugt DA; Meites J
    Fed Proc; 1980 Jun; 39(8):2533-8. PubMed ID: 6247213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro.
    Spangelo BL; Judd AM; Ross PC; Login IS; Jarvis WD; Badamchian M; Goldstein AL; MacLeod RM
    Endocrinology; 1987 Dec; 121(6):2035-43. PubMed ID: 2824178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer understanding of human hypothalamic-pituitary disease obtained through the use of synthetic hypothalamic hormones.
    Frohman LA
    Res Publ Assoc Res Nerv Ment Dis; 1978; 56():387-413. PubMed ID: 414315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.